Cancer

Scientists identify genetic drivers of common lymphoma

An international team of scientists has pinpointed the genetic drivers of diffuse large B-cell lymphoma—the most common type of blood cancer—and determined the genes' clinical significance. The study, published in the ...

Cancer

Endoscopic evaluation advised in non-Hodgkin's lymphoma

(HealthDay)—For elderly adults diagnosed with non-Hodgkin's lymphoma, endoscopic evaluation may be recommended even in the absence of gastrointestinal symptoms, according to a letter to the editor published in the August ...

Medications

Imbruvica approved for mantle cell lymphoma

(HealthDay)—Imbruvica (ibrutinib) has been approved by the U.S. Food and Drug Administration to treat mantle cell lymphoma (MCL), a rare but aggressive form of blood cancer.

Cancer

Triptorelin doesn't avert early ovarian failure in lymphoma

(HealthDay)—Treatment of lymphoma patients with the gonadotropin-releasing hormone agonist (GnRHa) triptorelin plus norethisterone does not reduce the rate of chemotherapy-induced premature ovarian failure (POF), according ...

Cancer

Rituximab plus lenalidomide effective in follicular lymphoma

(HealthDay)—Rituximab plus lenalidomide has similar efficacy to rituximab plus chemotherapy among patients with previously untreated follicular lymphoma, according to a study published in the Sept. 6 issue of the New England ...

Cancer

New treatment for non-Hodgkin lymphoma approved

(HealthDay)—Poteligeo (mogamulizumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with two types of non-Hodgkin lymphoma.

Cancer

New epigenetic drug against Mantle Cell Lymphoma

A new study by doctor Manel Esteller, Director of the Epigenetics and Cancer Biology Program (PEBC) of the Bellvitge Biomedical Research Institute (IDIBELL), ICREA Researcher and Professor of Genetics at the University of ...

page 12 from 23